Innovation Pharmaceuticals
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
301 Edgewater Pl Ste 100, Wakefield, Mas...Phone Number
(978) 921-4125Website
www.ipharminc.comRevenue
<$5 MillionStock Symbol
IPIXIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Innovation Pharmaceuticals
Innovation Pharmaceuticals Inc. is a clinical stage biopharmaceutical company focused on developing innovative therapies to combat infectious diseases and other medical conditions. Their lead product, Brilacidin, is an immunomodulatory drug candidate with broad-spectrum antimicrobial properties and potential applications in treating oral mucositis. The company is also developing a novel image-guided surgical laser platform for cancer and epilepsy treatment. Target clients include healthcare providers and patients in need of advanced medical therapies.Explore more
Innovation Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Innovation Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Innovation Pharmaceuticals had a recent Job posting/layoffs
Check out if Innovation Pharmaceuticals is spiking on competitors!
Check if Innovation Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Innovation Pharmaceuticals launches new products
Innovation Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Innovation Pharmaceuticals has new funding data
Congratulate Masked Content for being promoted to Masked Content at Innovation Pharmaceuticals
Earning: See what the market has to say on Innovation Pharmaceuticals recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Innovation Pharmaceuticals
Compare insights from companies similar to Innovation Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Innovation Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Innovation Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Innovation Pharmaceuticals.
Innovation Pharmaceuticals Tech Stack
A closer look at the technologies used by Innovation Pharmaceuticals
Innovation Pharmaceuticals News & Media
Innovation Pharma Announces BeaMed Technologies Breakthrough in Development of Fiber Optic Probes for StingRay Laser System; Paves Way for Groundbreaking Integration Testing
WAKEFIELD, MA, June 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company and minority stakeholder in BT BeaMed Technologies (“BeaMed”), is pleased to inform shareholders that BeaMed, a pioneering company dedicated to revolutionizing epilepsy and cancer surgery through laser-based innovations, reported significant progress in the development of its groundbreaking StingRay Laser system (the “StingRay SysInnovation Pharmaceuticals Visits BeaMed; New StingRay Laser System for Epilepsy and Brain Tumors Moving Toward FDA Submission
WAKEFIELD, MA, Feb. 23, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company and minority stakeholder in BT BeaMed Technologies (“BeaMed”), is pleased to inform shareholders that development of the BeaMed StingRay Laser System (the “StingRay System”) is progressing smoothly and ahead of estimated schedule. The Company’s Chief Executive Officer and other financial stakeholders in BeaMed recently returned frInnovation Pharmaceuticals Announces BT BeaMedical Technologies and Shina Systems Ltd. Enter into a Definitive Strategic Development Agreement
Multiyear Development and Support Agreement Lays the Foundation for the Realization of an Advanced Software Suite to Enable Revolutionary Treatments of Epilepsy and Brain TumorsInnovation Pharmaceuticals Announces BT BeaMedical Technologies Receives FDA Clearance for New Surgical Laser Family
Regulatory clearance lays key technological and regulatory foundation for BT BeaMedical’s vision of revolutionizing treatment options in neurosurgery, oncology, and a wide spectrum of other clinical specialties.
Read more news
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding Innovation Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Innovation Pharmaceuticals Inc. is a clinical stage biopharmaceutical company focused on developing innovative therapies to combat infectious diseases and other medical conditions. Their lead product, Brilacidin, is an immunomodulatory drug candidate with broad-spectrum antimicrobial properties and potential applications in treating oral mucositis.... Read More
